Call for Abstracts and Travel Awards: All authors notified by email  ︎  18 invited speakers confirmed  ︎  Save your seat! Register here until October 7  ︎  Check the programme at a glance  ︎  Interested in joining the team of volunteers? Apply now!   ︎  Become a partner of #CRSy22  ︎ 
︎    ︎    ︎    

Alexander Schäffer


PhD Candidate @ Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy



Alexander Schäffer is a trained molecular biologist having received a bachelor’s degree in biology from the Hamburg University with specialization in genetics and immunology and master’s degree in molecular medicine focusing on cancer biology from the Goethe University (Frankfurt, Germany).

He has previously gained research experience in the group of Lisa Westerberg at the Karolinska Institute (Stockholm, Sweden) where he worked on immunodeficiency syndromes. Additionally, he investigated the therapeutic targeting of tumor-associated macrophages and microglia in the tumor microenvironment of brain metastasis in the group of Lisa Sevenich.

After his master studies, he joined the group of Hind Medyouf at the Institute for Tumor Biology and Experimental Therapy (Frankfurt, Germany) as PhD student. His PhD project is aiming to elucidate the impact of aging on dormancy dynamics in human bone metastasis as well as the establishment of novel 3D human organotypic marrow environments (3D-HOMEs).

This symposium is supported by QuantOCancer Project funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement Nº 810653.